OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. O'Shaughnessy Describes the School of Breast Oncology

October 3rd 2011

Dr. Joyce A. O'Shaughnessy from the Baylor Sammons Cancer Center Describes the School of Breast Oncology

Dr. Mills Explains the Vulnerability of Cancer Cells

October 3rd 2011

Dr. Gordon Mills from MD Anderson Cancer Center Explains the Vulnerability of Cancer Cells

Dr. Morrow Describes the ACOSOG Z11 Trial

September 30th 2011

Dr. Monica Morrow from Memorial Sloan-Kettering Cancer Center Describes the ACOSOG Z11 Trial

Dr. Wakelee on Adjuvant Therapy Predictive Markers

September 30th 2011

Dr. Heather Wakelee from Stanford Clinical Cancer Center Discusses Adjuvant Therapy Predictive Markers

Joanna Morales Explains Cancer Related Legal Issues

September 29th 2011

Joanna Morales from the Cancer Legal Resource Center Explains Cancer Related Legal Issues

Dr. Mills on the Shifts Towards Personalized Medicine

September 29th 2011

Dr. Gordon B. Mills from MD Anderson Cancer Center Discusses Shifts Towards Personalized Medicine

Dr. Dixon on Systems Biology for Combination Therapy

September 28th 2011

Dr. Michael Dixon from University of Edinburgh on Systems Biology Determining Therapy Combinations

Dr. Burtness on the Head and Neck Symposium Design

September 28th 2011

Dr. Barbara Burtness from Fox Chase Cancer Center on the Head and Neck Symposium Design

Dr. Scagliotti on the Benefits of EGFR Targeted Therapy

September 27th 2011

Dr. Giorgio Scagliotti from the University of Turin in Italy on EGFR Targeted Therapy Survival Benefits

Dr. Burtness on the Head and Neck Cancer Symposium

September 27th 2011

Dr. Barbara Burtness from Fox Chase Cancer Center Discusses the Upcoming Head and Neck Cancer Symposium

Dr. Ellis on Genome Forward Breast Cancer Treatment

September 26th 2011

Dr. Matthew Ellis from Washington University, St Louis, Discusses Genome Forward Breast Cancer Treatment

Dr. Yoneda Discusses Pulmonary Nodules

September 23rd 2011

Dr. Ken Y. Yoneda from UC Davis Cancer Center Discusses Pulmonary Nodules

Dr. McDonald on Approved Angiogenesis Inhibitors

September 22nd 2011

Dr. Donald McDonald from UCSF Comprehensive Cancer Center Explains Approved Angiogenesis Inhibitors

Dr. Wakelee on Explaining Adjuvant Therapy to Patients

September 21st 2011

Dr. Heather Wakelee from Stanford Clinical Cancer Center on Explaining Adjuvant Therapy to Patients

Dr. Tripathy Discusses Breast Carcinoma Heterogeneity

September 20th 2011

Dr. Debu Tripathy from Norris Comprehensive Cancer Center Discusses Breast Carcinoma Heterogeneity

Dr. Li Describes the Future of Lung Cancer Therapy

September 19th 2011

Dr. Tianhong Li from University of California Davis Cancer Center Describes the Future of Lung Cancer Therapy

Dr. Rugo on VEGF-A as an Avastin Response Predictor

September 16th 2011

Dr. Hope Rugo from UCSF Cancer Center on VEGF-A as an Avastin Response Predictor

Dr. Scagliotti Discusses EGFR Mutations in NSCLC

September 16th 2011

Dr. Giorgio Scagliotti from University of Turin Discusses EGFR Mutations in non-small cell lung cancer

Dr. Dixon on Letrozole With Pathway Inhibitors

September 15th 2011

Dr. J. Michael Dixon from University of Edinburgh on Letrozole Used in Combination With Pathway Inhibitors

Dr. O'Shaughnessy on the Future of TNBC Treatment

September 15th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on the Future of Triple Negative Breast Cancer Treatment